The company is betting that margin gains from integration can translate into product innovation that locks in enterprise ...
StockStory.org on MSN
DXCM Q3 deep dive: Clinical momentum and new product launches support growth trajectory
Medical device company DexCom (NASDAQ:DXCM) reported in Q3 2026, with sales up 11.2% year on year to $1.34 billion. The ...
For enthusiasts and average drivers alike, having your car stolen is an absolute nightmare. To help prevent this scenario, we ...
Hot dogs, raw milk cheese, frozen berries and even kids’ toys are among the items regulators have flagged in recent weeks.
The headline numbers for CBOE (CBOE) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street ...
Fee cuts and slower lending growth signal a strategic shift toward deposit stability over loan volume.
The 613% revenue jump plus profit rebound signals real pricing power from tight supply, and CXMT is positioned to benefit ...
ALAMEDA, Calif.-- (BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of ...
As AI becomes a popular tool for gift recommendations, a global study finds shoppers continue to rely on everyday consumers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results